Hong Kong
# |
Name |
Price to Earnings Ratio (P/E) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
55.23 |
Jan. 14, 2025 | USD 0.43 | 2.74% |
|
Hong Kong |
|
2 |
44.90 |
Jan. 14, 2025 | USD 0.16 | -0.02% |
|
Hong Kong |
|
3 |
38.59 |
Jan. 14, 2025 | USD 0.25 | 3.70% |
|
Hong Kong |
|
4 |
37.49 |
Jan. 14, 2025 | USD 0.21 | 8.82% |
|
Hong Kong |
|
5 |
26.73 |
Jan. 14, 2025 | USD 0.83 | 3.07% |
|
Hong Kong |
|
6 |
23.03 |
Jan. 14, 2025 | USD 3.02 | 2.59% |
|
Hong Kong |
|
7 |
20.41 |
Jan. 14, 2025 | USD 0.37 | 1.03% |
|
Hong Kong |
|
8 |
19.61 |
Jan. 14, 2025 | USD 0.21 | 10.11% |
|
Hong Kong |
|
9 |
12.49 |
Jan. 14, 2025 | USD 1.04 | 1.48% |
|
Hong Kong |
|
10 |
10.53 |
Jan. 14, 2025 | USD 0.22 | -1.75% |
|
Hong Kong |
|
11 |
9.36 |
Jan. 14, 2025 | USD 0.44 | -0.60% |
|
Hong Kong |
|
12 |
8.55 |
Jan. 14, 2025 | USD 0.27 | 0.92% |
|
Hong Kong |
|
13 |
8.49 |
Jan. 14, 2025 | USD 0.47 | -0.57% |
|
Hong Kong |
|
14 |
8.40 |
Jan. 14, 2025 | USD 0.67 | 1.53% |
|
Hong Kong |
|
15 |
7.87 |
Jan. 14, 2025 | USD 0.49 | 2.14% |
|
Hong Kong |
|
16 |
7.47 |
Jan. 14, 2025 | USD 0.13 | 1.98% |
|
Hong Kong |
|
17 |
7.38 |
Jan. 14, 2025 | USD 0.31 | 0.39% |
|
Hong Kong |
|
18 |
7.32 |
Jan. 14, 2025 | USD 0.26 | 1.45% |
|
Hong Kong |
|
19 |
7.12 |
Jan. 14, 2025 | USD 0.41 | 1.55% |
|
Hong Kong |
|
20 |
6.58 |
Jan. 14, 2025 | USD 1.42 | 0.70% |
|
Hong Kong |
|
21 |
6.48 |
Jan. 14, 2025 | USD 0.91 | -0.72% |
|
Hong Kong |
|
22 |
4.99 |
Jan. 14, 2025 | USD 0.15 | -0.02% |
|
Hong Kong |
|
23 |
4.82 |
Jan. 14, 2025 | USD 0.18 | -0.02% |
|
Hong Kong |
|
24 |
-0.52 |
Jan. 14, 2025 | USD 0.39 | 0.30% |
|
Hong Kong |
|
25 |
-4.05 |
Jan. 14, 2025 | USD 0.13 | -1.02% |
|
Hong Kong |
|
26 |
-24.88 |
Jan. 14, 2025 | USD 14.74 | 7.67% |
|
Hong Kong |
|
27 |
-43.91 |
Jan. 13, 2025 | USD 0.10 | 0.02% |
|
Hong Kong |
The Pharmaceuticals company in Hong Kong with the highest Price to Earnings Ratio (P/E) is Alibaba Health Information Technology Limited (HKSE: 0241.HK) at 55.23.
The Pharmaceuticals company in Hong Kong with the lowest Price to Earnings Ratio (P/E) is Yunnan Energy International Co. Limited (HKSE: 1298.HK) at -43.91.
The top 10 Pharmaceuticals companies in Hong Kong by Price to Earnings Ratio (P/E) are Alibaba Health Information Technology Limited, Lee's Pharmaceutical Holdings Limited, C-MER Eye Care Holdings Limited, Frontage Holdings Corporation, Guangdong Hybribio Biotech Co.,Ltd., HUTCHMED (China) Limited, Sino Biopharmaceutical Limited, Chia Tai Enterprises International Limited, Beijing Tong Ren Tang Chinese Medicine Company Limited and JBM (Healthcare) Limited.
The bottom 10 Pharmaceuticals companies in Hong Kong by Price to Earnings Ratio (P/E) are Yunnan Energy International Co. Limited, BeiGene, Ltd., SinoMab BioScience Limited, Sirnaomics Ltd., Jilin Province Huinan Changlong Bio-pharmacy Company Limited, Dawnrays Pharmaceutical (Holdings) Limited, China Medical System Holdings Limited, The United Laboratories International Holdings Limited, SSY Group Limited and China Traditional Chinese Medicine Holdings Co. Limited.